Cove Private Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Buy
+8,656
New +$372K 0.08% 157
2025
Q1
Sell
-2,494
Closed -$215K 123
2024
Q4
$215K Buy
+2,494
New +$270K 0.13% 105

Other funds holding NVO

Cove Private Wealth's NVO Position: Q2 2026 in Review

Cove Private Wealth opened a new position in Novo Nordisk (NVO) in Q2 2026: 8,656 shares worth $415K. The stake represents 0.08% of the portfolio and ranks #157 among its holdings. This is a return to the name: Cove Private Wealth previously reported a position in NVO as recently as Q4 2024.

Cove Private Wealth first reported a position in NVO in Q4 2024 and has held it in 2 quarters since. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cove Private Wealth held 8,656 shares of Novo Nordisk worth $415K as of Q2 2026.
  • Novo Nordisk was a new Cove Private Wealth position in Q2 2026.
  • Novo Nordisk made up 0.08% of Cove Private Wealth's portfolio in Q2 2026, its #157 holding.
  • Cove Private Wealth first reported a position in Novo Nordisk in Q4 2024 and has held it in 2 quarters since.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.